Navigation Links
Johnson & Johnson honors 2008 recipients of the Dr. Paul Janssen Award for Biomedical Research
Date:9/10/2008

Beerse, Belgium September 10, 2008 The 2008 recipients of The Dr. Paul Janssen Award for Biomedical Research, Professor Marc Feldmann, FMedSci, FAA, FRS and Emeritus Professor Sir Ravinder Maini, FRCP, FMedSci, FRS of the Kennedy Institute of Rheumatology, Imperial College London, are being honored during a scientific symposium today and at a formal award ceremony at the Dr. Paul Janssen Research Center in Beerse, Belgium tomorrow. Feldmann and Maini received the $100,000 prize for their role in the discovery of tumor necrosis factor-alpha (TNF-alpha) as an effective therapeutic target for rheumatoid arthritis and other chronic inflammatory conditions.

"Thanks to their pioneering biomedical research, Feldmann and Maini have significantly improved the lives of millions of patients with chronic inflammatory conditions," said Paul Stoffels, company group chairman, Global Research and Development, Pharmaceuticals, Johnson & Johnson. "We are delighted that the 2008 Dr. Paul Janssen Award is going to two researchers with a lifelong commitment to translational research. Their achievements would have been greatly appreciated by Dr. Paul Janssen, who himself was instrumental in the development of many important medicines."

For more than 20 years, Feldmann and Maini have collaborated on basic research and clinical trials that have transformed the treatment of people diagnosed with chronic inflammatory conditions. Feldmann and Maini investigated the role of cytokines, protein messenger molecules that drive inflammation, and found that a single cytokine, TNF-alpha, was responsible for the debilitating symptoms of inflammatory disease. In seeking ways to block TNF-alpha, they studied a monoclonal antibody previously developed for an unrelated condition. Clinical trials revealed rapid and dramatic improvement of rheumatoid disease activity with anti-TNF therapy, ultimately influencing the development of several anti-TNF drugs that are used routine
'/>"/>

Contact: Lisa Vaga
lvaga@its.jnj.com
908-670-0363
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Eli and Edythe L. Broad make unprecedented gift to endow Broad Institute of Harvard & MIT
2. M&Ms as diet food? 100-calorie pack misconceptions
3. Genetic Engineering & Biotechnology News reports on novel hit-to-lead drug discovery
4. Texas A&M researchers develop tool to study complex clusters of genes
5. Treating chronic pain, migraine & muscle spasticity through inhibition of neurotransmitter glutamate
6. Male seahorses are natures Mr. Mom, Texas A&M researchers say
7. Nobel laureate Dr. Linda Buck elected to American Academy of Arts & Sciences 2008 Class of Fellows
8. SAGE launches new journal -- ICAN: Infant, Child, & Adolescent Nutrition
9. Genetic Engineering & Biotechnology News reports on growing use of cell-based assays
10. AMNH scientists grace Science & Nature covers
11. Genetic Engineering & Biotechnology News reports on cancer biomarkers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...the Netherlands, November 09, 2009 / b3c newswire...ization, and Seventh Wave, an American organizatio...that the companies have signed a letter of intent ...tinal models TIM. The letter of intent proposes a ...o TIM systems for commercialization in North Ameri...
(Date:11/9/2009)...ELPHIA Scientists and industry leaders from aroun..., for the AACR-NCI-EORTC Molecular Targets and Can...ill feature groundbreaking information on importan... a complex disease and to treat it effectively we ...takes place at the molecular level," said Lewis Ca...
(Date:11/8/2009)...T LAFAYETTE, Ind. - Researchers at Purdue Universi...maged nerve fibers in spinal cord injuries using n...shortly after an accident. , The synthetic "copo... nanometers in diameter, or roughly 100 times smal...earchers have been studying how to deliver drugs f...
Breaking Biology News(10 mins):TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 2Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Depression May Lead to More Preemies Among Blacks 49006 1Depression May Lead to More Preemies Among Blacks 49006 2Good news for some hard to treat hepatitis C patients 49004 1Good news for some hard to treat hepatitis C patients 49004 2Nuvo Research and Covidien sign U S license and development agreement for Pennsaid 28R 29 and Pennsaid Plus 28R 29 49003 1Nuvo Research and Covidien sign U S license and development agreement for Pennsaid 28R 29 and Pennsaid Plus 28R 29 49003 2Nuvo Research and Covidien sign U S license and development agreement for Pennsaid 28R 29 and Pennsaid Plus 28R 29 49003 3
...mmals React to Underwater Sound , Connie Barclay,...ries Service is looking at how marine mammals reac...ts that exposure to intense underwater sound in so...rand and ultimately die. Some of these strandings ...itary sonar, and most have involved beaked whales;...
... newly sequenced genome of a one-celled, planktoni...14) in the journal Nature, is already telling scie...nied the jump from one-celled life forms to multic...aper and a complementary Science paper also releas...biologists Nicole King, Daniel Rokhsar and their c...
...vast and far-reaching as the worlds oceans are, ev...es, according to a study in the journal Science by...t Chapel Hill and others. , The international tea...ects of global change from overfishing to global ...ems, such as coral reefs and continental shelves. ...
Other Biology News:NOAA science story tips -- AAAS 2008 edition 2NOAA science story tips -- AAAS 2008 edition 3NOAA science story tips -- AAAS 2008 edition 4NOAA science story tips -- AAAS 2008 edition 5NOAA science story tips -- AAAS 2008 edition 6NOAA science story tips -- AAAS 2008 edition 7Genome of marine organism tells of humans' unicellular ancestors 2Genome of marine organism tells of humans' unicellular ancestors 3Genome of marine organism tells of humans' unicellular ancestors 4First map of threats to marine ecosystems shows all the world's oceans are affected 2
(Date:11/6/2009)...v. 6 ,, 3Q09 Corpo...tenza(TM) E.U. Marketing Authorization to Astellas... commercial readiness activities Expanded managem...keting; and Director, Commercial Operations Appoi...Audit Committee chairman , Upcoming 2009 Mi...
(Date:11/6/2009)...he agenda for Arrowhead’s 2010 Personalized ...take place on February 22-24, 2010 in Philadelphia... we will highlight key issues in forming partnersh...periences. , Minneapolis,...owhead’s 2010 Personalized Medicine Partner...
(Date:11/5/2009).... 5 DSM Pharmaceutical Products to...iance with Galenix, Saint Jean D,Illac, France, wh...ufacturing partner for Galenix commercial products...laborate on business development opportunities co-...d on the strength of Galenix in drug product devel...
(Date:11/5/2009)...PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC B...ults for the quarter ended September 30, 2009. The...tables that follow. ,, Third Quarter 2009 ,...$0.01 per share for the third quarter of 2009 as c...re for the third quarter of 2008. ,, Net sales...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...b3c newswire /  - Rentschler Biotechnologie a... biopharmaceutical development and production, hav...operation will enable Rentschler Biotechnologie&rs...im’s large-scale mammalian biopharmaceutical...ce versa, Boehringer Ingelheim’s clients to ...
...rapeutics (Prime), a,thought leader in pharmacy be...ived accreditation from the National Association o...fied Internet Pharmacy Practice,Sites(TM) (VIPPS(R...tablished by NABP in response to,consumers, concer...he,Internet. VIPPS accreditation further authentic...
...stems, Inc., a,privately held company that manufac...nnounced today the newest installation of the PEM ... P.C. in Rockville Centre, New York.,This installa...een Naviscan,and the operators of Rockville PET Im...ging technology to multiple centers throughout the...
Other Biology Technology:Rentschler Biotechnologie Announces Cooperation with Boehringer Ingelheim 2Rentschler Biotechnologie Announces Cooperation with Boehringer Ingelheim 3Prime Therapeutics Receives VIPPS Accreditation 2Naviscan PET Systems and Rockville PET Imaging Partner to Bring a New Breast Imaging Technology to New York 2Naviscan PET Systems and Rockville PET Imaging Partner to Bring a New Breast Imaging Technology to New York 3
Ribonucleic acid, transfer from baker's yeast (S. cerevisiae) from Sigma-Aldrich
Ribonucleic acid, transfer from baker's yeast (S. cerevisiae) from Sigma-Aldrich
...ct measuring instrument for calibrating single-cha...ompact design and the robust carrying case, the MC... laboratory and on-site at the users premises. The...ual channels are tested automatically. Multi-chann...
...tol DTT White solid.. PACKAGED UNDER INERT GAS. ...action is "driven" to completion. A protective age... found in many other preparations. Blocks the leth... ≥97% by titration. Contaminants: Heavy metal...
Biology Products: